PeptiDream is Biotechnology in Japan that focus on conjugate therapeutics business. Founded in 2006. They cover business area such as PeptiDream Inc, development, new pharmaceutical candidate, constrain peptide, small molecule, peptide-drug conjugate therapeutic, its Peptide Discovery Platform System, drug discovery, unmet medical need, life, patient.
2006
( 18 years old in 2024 )
Conjugate Therapeutics
-
Business Offices, KOL Building, Room 405, Research Labs, KOL Building, 4th floor
Komaba Resaerch Campus (Komaba II), The University of Tokyo), 4-6-1 Komaba, Meguro-ku
Tokyo, 153-8904
Japan
Private
PeptiDream Incdevelopmentnew pharmaceutical candidateconstrain peptidesmall moleculepeptide-drug conjugate therapeuticits Peptide Discovery Platform Systemdrug discoveryunmet medical needlifepatient
* We use standard office opening hours in near PeptiDream's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PeptiDream is Biotechnology business from Japan that founded in 2006 (18 years old in 2024), PeptiDream business is focusing on Conjugate Therapeutics.
PeptiDream headquarter office and corporate office address is located in Business Offices, KOL Building, Room 405, Research Labs, KOL Building, 4th floor Komaba Resaerch Campus (Komaba II), The University of Tokyo), 4-6-1 Komaba, Meguro-ku Tokyo, 153-8904 Japan.
PeptiDream was founded in Japan.
In 2024, PeptiDream is currently focus on conjugate therapeutics sector.
Above is snippet of Google Trends for "conjugate therapeutics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PeptiDream, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
